{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T10:21:30Z","timestamp":1794392490121,"version":"4.9.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271872"],"award-info":[{"award-number":["82271872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1801003"],"award-info":[{"award-number":["2022YFD1801003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Innovation Leading Team Program of Guangzhou City","award":["202009020009"],"award-info":[{"award-number":["202009020009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03156-w","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:35:55Z","timestamp":1738128955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhaoyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deming","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanbo","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"7984","key":"3156_CR1","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-023-06631-2","volume":"622","author":"R Xie","year":"2023","unstructured":"Xie R, Edwards KM, Wille M, Wei X, Wong SS, Zanin M, et al. The episodic resurgence of highly pathogenic avian influenza H5 virus. Nature. 2023;622(7984):810\u20137.","journal-title":"Nature"},{"issue":"6592","key":"3156_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1126\/science.abo1232","volume":"376","author":"M Wille","year":"2022","unstructured":"Wille M, Barr IG. Resurgence of avian influenza virus. Science. 2022;376(6592):459\u201360.","journal-title":"Science"},{"issue":"4","key":"3156_CR3","first-page":"e07289","volume":"20","author":"C Adlhoch","year":"2022","unstructured":"Adlhoch C, Fusaro A, Gonzales JL, Kuiken T, Marangon S, Niqueux \u00c9, et al. Avian influenza overview December 2021 - March 2022. EFSA J. 2022;20(4):e07289.","journal-title":"EFSA J"},{"issue":"3","key":"3156_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/vetr.3316","volume":"193","author":"M Limb","year":"2023","unstructured":"Limb M. Fears for human cases of avian influenza. Vet Rec. 2023;193(3):93\u201393.","journal-title":"Vet Rec"},{"key":"3156_CR5","unstructured":"Avian Influenza situation reports in 2023. [https:\/\/www.woah.org\/en\/disease\/avian-influenza\/#ui-id-2]"},{"key":"3156_CR6","doi-asserted-by":"crossref","unstructured":"Puryear WB, Runstadler JA. High-pathogenicity avian influenza in wildlife: a changing disease dynamic that is expanding in wild birds and having an increasing impact on a growing number of mammals. J Am Vet Med Assoc 2024:1\u20139.","DOI":"10.2460\/javma.24.01.0053"},{"issue":"1","key":"3156_CR7","doi-asserted-by":"publisher","first-page":"2155072","DOI":"10.1080\/22221751.2022.2155072","volume":"12","author":"J Shi","year":"2023","unstructured":"Shi J, Zeng X, Cui P, Yan C, Chen H. Alarming situation of emerging H5 and H7 avian influenza and effective control strategies. Emerg Microbes Infect. 2023;12(1):2155072.","journal-title":"Emerg Microbes Infect"},{"key":"3156_CR8","doi-asserted-by":"publisher","first-page":"711997","DOI":"10.3389\/fimmu.2021.711997","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Wang J, Zhang J, Ly H. Advances in Development and Application of Influenza vaccines. Front Immunol. 2021;12:711997.","journal-title":"Front Immunol"},{"key":"3156_CR9","doi-asserted-by":"publisher","first-page":"774630","DOI":"10.3389\/fvets.2021.774630","volume":"8","author":"J Hu","year":"2021","unstructured":"Hu J, Peng P, Li J, Zhang Q, Li R, Wang X, et al. Single dose of Bivalent H5 and H7 Influenza Virus-Like particle protects chickens against highly pathogenic H5N1 and H7N9 avian influenza viruses. Front Vet Sci. 2021;8:774630.","journal-title":"Front Vet Sci"},{"key":"3156_CR10","doi-asserted-by":"crossref","unstructured":"Kong D, He Y, Wang J, Chi L, Ao X, Ye H et al. A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage. Emerg Microbes Infect 2023:2287682.","DOI":"10.1080\/22221751.2023.2287682"},{"key":"3156_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fimmu.2018.00320","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL. Host Immune Response to Influenza A Virus infection. Front Immunol. 2018;9:320.","journal-title":"Front Immunol"},{"issue":"42","key":"3156_CR12","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1016\/j.vaccine.2019.08.071","volume":"37","author":"D Smith","year":"2019","unstructured":"Smith D, Streatfield SJ, Acosta H, Ganesan S, Fattom A. A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge. Vaccine. 2019;37(42):6162\u201370.","journal-title":"Vaccine"},{"key":"3156_CR13","doi-asserted-by":"crossref","unstructured":"Bettini E, Locci M. SARS-CoV-2 mRNA vaccines: immunological mechanism and Beyond. Vaccines (Basel) 2021; 9(2).","DOI":"10.3390\/vaccines9020147"},{"key":"3156_CR14","doi-asserted-by":"crossref","unstructured":"Echaide M, Chocarro de Erauso L, Bocanegra A, Blanco E, Kochan G, Escors D. mRNA vaccines against SARS-CoV-2: advantages and caveats. Int J Mol Sci 2023; 24(6).","DOI":"10.3390\/ijms24065944"},{"issue":"6","key":"3156_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/08971900211009650","volume":"35","author":"SP Teo","year":"2022","unstructured":"Teo SP. Review of COVID-19 mRNA vaccines: BNT162b2 and mRNA-1273. J Pharm Pract. 2022;35(6):947\u201351.","journal-title":"J Pharm Pract"},{"issue":"7830","key":"3156_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586(7830):567\u201371.","journal-title":"Nature"},{"issue":"1","key":"3156_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12985-022-01919-7","volume":"19","author":"J Li","year":"2022","unstructured":"Li J, Liu Q, Liu J, Wu X, Lei Y, Li S, et al. An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs. Virol J. 2022;19(1):184.","journal-title":"Virol J"},{"issue":"2","key":"3156_CR18","doi-asserted-by":"publisher","first-page":"2270081","DOI":"10.1080\/22221751.2023.2270081","volume":"12","author":"J Wan","year":"2023","unstructured":"Wan J, Yang J, Wang Z, Shen R, Zhang C, Wu Y, et al. A single immunization with core-shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs. Emerg Microbes Infect. 2023;12(2):2270081.","journal-title":"Emerg Microbes Infect"},{"key":"3156_CR19","doi-asserted-by":"crossref","unstructured":"G\u00f3mez CE, Perdiguero B, Usero L, Marcos-Villar L, Miralles L, Leal L et al. Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA vaccine through boosting with a Poxvirus MVA Vector expressing the same Antigen. Vaccines (Basel) 2021; 9(9).","DOI":"10.3390\/vaccines9090959"},{"issue":"3","key":"3156_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/infdis\/jix592","volume":"217","author":"M Meyer","year":"2018","unstructured":"Meyer M, Huang E, Yuzhakov O, Ramanathan P, Ciaramella G, Bukreyev A. Modified mRNA-Based vaccines elicit robust Immune responses and protect Guinea pigs from Ebola Virus Disease. J Infect Dis. 2018;217(3):451\u20135.","journal-title":"J Infect Dis"},{"issue":"6","key":"3156_CR21","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, et al. Modified mRNA vaccines protect against Zika Virus infection. Cell. 2017;168(6):1114\u2013e11251110.","journal-title":"Cell"},{"key":"3156_CR22","doi-asserted-by":"crossref","unstructured":"Lin K, Cao H, Luan N, Wang Y, Hu J, Liu C. Comparison of the Immune effects of an mRNA vaccine and a Subunit vaccine against herpes zoster administered by different injection methods. Vaccines (Basel) 2023; 11(5).","DOI":"10.3390\/vaccines11051003"},{"key":"3156_CR23","doi-asserted-by":"publisher","first-page":"1129118","DOI":"10.3389\/fimmu.2023.1129118","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, Lu X, Li X, Huang W, Fang E, Li W, et al. Construction and immunogenicity of an mRNA vaccine against Chikungunya virus. Front Immunol. 2023;14:1129118.","journal-title":"Front Immunol"},{"issue":"1","key":"3156_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41541-020-0163-z","volume":"5","author":"AS Espeseth","year":"2020","unstructured":"Espeseth AS, Cejas PJ, Citron MP, Wang D, DiStefano DJ, Callahan C, et al. Modified mRNA\/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. NPJ Vaccines. 2020;5(1):16.","journal-title":"NPJ Vaccines"},{"issue":"5","key":"3156_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1080\/21645515.2020.1829899","volume":"17","author":"AO Aliprantis","year":"2021","unstructured":"Aliprantis AO, Shaw CA, Griffin P, Farinola N, Railkar RA, Cao X, et al. A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Hum Vaccin Immunother. 2021;17(5):1248\u201361.","journal-title":"Hum Vaccin Immunother"},{"issue":"6622","key":"3156_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1126\/science.abm0271","volume":"378","author":"CP Arevalo","year":"2022","unstructured":"Arevalo CP, Bolton MJ, Le Sage V, Ye N, Furey C, Muramatsu H, et al. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science. 2022;378(6622):899\u2013904.","journal-title":"Science"},{"issue":"1","key":"3156_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41541-023-00752-5","volume":"8","author":"CM Kackos","year":"2023","unstructured":"Kackos CM, DeBeauchamp J, Davitt CJH, Lonzaric J, Sealy RE, Hurwitz JL, et al. Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection. NPJ Vaccines. 2023;8(1):157.","journal-title":"NPJ Vaccines"},{"issue":"1","key":"3156_CR28","doi-asserted-by":"publisher","first-page":"2309985","DOI":"10.1080\/22221751.2024.2309985","volume":"13","author":"L Huang","year":"2024","unstructured":"Huang L, Zhao T, Zhao W, Shao A, Zhao H, Ma W, et al. Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques. Emerg Microbes Infect. 2024;13(1):2309985.","journal-title":"Emerg Microbes Infect"},{"key":"3156_CR29","doi-asserted-by":"crossref","unstructured":"Kong D, Chen T, Hu X, Lin S, Gao Y, Ju C et al. Supplementation of H7N9 Virus-Like particle vaccine with recombinant epitope Antigen confers full protection against Antigenically Divergent H7N9 virus in chickens. Front Immunol 2022; 13.","DOI":"10.3389\/fimmu.2022.785975"},{"key":"3156_CR30","doi-asserted-by":"crossref","unstructured":"Chen T, Kong D, Hu X, Gao Y, Lin S, Liao M et al. Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability and Provides Effective Immune Protection against Lethal H7N9 Virus Challenge in Chickens. Vaccines (Basel). 2023; 11(8).","DOI":"10.3390\/vaccines11081318"},{"key":"3156_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijbiomac.2016.05.066","volume":"100","author":"VI Muronetz","year":"2017","unstructured":"Muronetz VI, Barinova KV, Stroylova YY, Semenyuk PI, Schmalhausen EV. Glyceraldehyde-3-phosphate dehydrogenase: aggregation mechanisms and impact on amyloid neurodegenerative diseases. Int J Biol Macromol. 2017;100:55\u201366.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3156_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41421-023-00571-x","volume":"9","author":"P Huang","year":"2023","unstructured":"Huang P, Sun L, Li J, Wu Q, Rezaei N, Jiang S, et al. Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines. Cell Discov. 2023;9(1):58.","journal-title":"Cell Discov"},{"issue":"4","key":"3156_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 4","key":"3156_CR34","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","volume":"26","author":"NM Bouvier","year":"2008","unstructured":"Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26(Suppl 4):D49\u201353.","journal-title":"Vaccine"},{"key":"3156_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.coi.2014.02.005","volume":"28","author":"GA Kirchenbaum","year":"2014","unstructured":"Kirchenbaum GA, Ross TM. Eliciting broadly protective antibody responses against influenza. Curr Opin Immunol. 2014;28:71\u20136.","journal-title":"Curr Opin Immunol"},{"key":"3156_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.omtm.2021.06.003","volume":"22","author":"AW Freyn","year":"2021","unstructured":"Freyn AW, Pine M, Rosado VC, Benz M, Muramatsu H, Beattie M, et al. Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Mol Ther Methods Clin Dev. 2021;22:84\u201395.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3156_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","volume":"217","author":"N Pardi","year":"2015","unstructured":"Pardi N, Tuyishime S, Muramatsu H, Kariko K, Mui BL, Tam YK, et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release. 2015;217:345\u201351.","journal-title":"J Control Release"},{"key":"3156_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","volume":"170","author":"J Kim","year":"2021","unstructured":"Kim J, Eygeris Y, Gupta M, Sahay G. Self-assembled mRNA vaccines. Adv Drug Deliv Rev. 2021;170:83\u2013112.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6836","key":"3156_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/35078099","volume":"411","author":"FD Batista","year":"2001","unstructured":"Batista FD, Iber D, Neuberger MS. B cells acquire antigen from target cells after synapse formation. Nature. 2001;411(6836):489\u201394.","journal-title":"Nature"},{"key":"3156_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","volume":"333","author":"R Verbeke","year":"2021","unstructured":"Verbeke R, Lentacker I, De Smedt SC, Dewitte H. The dawn of mRNA vaccines: the COVID-19 case. J Control Release. 2021;333:511\u201320.","journal-title":"J Control Release"},{"key":"3156_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fimmu.2012.00009","volume":"3","author":"C M\u00fcnz","year":"2012","unstructured":"M\u00fcnz C. Antigen Processing for MHC class II presentation via Autophagy. Front Immunol. 2012;3:9.","journal-title":"Front Immunol"},{"issue":"5","key":"3156_CR42","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/mt.2012.11","volume":"20","author":"AM Van Nuffel","year":"2012","unstructured":"Van Nuffel AM, Benteyn D, Wilgenhof S, Pierret L, Corthals J, Heirman C, et al. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4\u2009+\u2009and CD8\u2009+\u2009T cells in melanoma patients. Mol Ther. 2012;20(5):1063\u201374.","journal-title":"Mol Ther"},{"key":"3156_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fimmu.2015.00464","volume":"6","author":"CS Leung","year":"2015","unstructured":"Leung CS. Endogenous Antigen presentation of MHC class II epitopes through non-autophagic pathways. Front Immunol. 2015;6:464.","journal-title":"Front Immunol"},{"issue":"1","key":"3156_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12985-017-0918-y","volume":"15","author":"GA Sautto","year":"2018","unstructured":"Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018;15(1):17.","journal-title":"Virol J"},{"issue":"12","key":"3156_CR45","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/infdis\/jix173","volume":"215","author":"AS Monto","year":"2017","unstructured":"Monto AS, Malosh RE, Petrie JG, Martin ET. The doctrine of original antigenic sin: separating good from evil. J Infect Dis. 2017;215(12):1782\u20138.","journal-title":"J Infect Dis"},{"issue":"4","key":"3156_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","volume":"23","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer R, Krammer F. Universal influenza virus vaccines and therapeutic antibodies. Clin Microbiol Infect. 2017;23(4):222\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"3156_CR47","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm.3927","volume":"21","author":"HM Yassine","year":"2015","unstructured":"Yassine HM, Boyington JC, McTamney PM, Wei CJ, Kanekiyo M, Kong WP, et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med. 2015;21(9):1065\u201370.","journal-title":"Nat Med"},{"key":"3156_CR48","doi-asserted-by":"publisher","first-page":"22666","DOI":"10.1038\/srep22666","volume":"6","author":"SA Valkenburg","year":"2016","unstructured":"Valkenburg SA, Mallajosyula VV, Li OT, Chin AW, Carnell G, Temperton N, et al. Stalking influenza by vaccination with pre-fusion headless HA mini-stem. Sci Rep. 2016;6:22666.","journal-title":"Sci Rep"},{"issue":"25","key":"3156_CR49","doi-asserted-by":"publisher","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","volume":"111","author":"VV Mallajosyula","year":"2014","unstructured":"Mallajosyula VV, Citron M, Ferrara F, Lu X, Callahan C, Heidecker GJ, et al. Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proc Natl Acad Sci U S A. 2014;111(25):E2514\u20132523.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3156_CR50","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1128\/JVI.02608-13","volume":"88","author":"D Eggink","year":"2014","unstructured":"Eggink D, Goff PH, Palese P. Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain. J Virol. 2014;88(1):699\u2013704.","journal-title":"J Virol"},{"issue":"7","key":"3156_CR51","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","volume":"28","author":"AW Freyn","year":"2020","unstructured":"Freyn AW, Ramos da Silva J, Rosado VC, Bliss CM, Pine M, Mui BL, et al. A Multi-targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine provides Broad Protection in mice. Mol Ther. 2020;28(7):1569\u201384.","journal-title":"Mol Ther"},{"issue":"45","key":"3156_CR52","doi-asserted-by":"publisher","first-page":"e2206333119","DOI":"10.1073\/pnas.2206333119","volume":"119","author":"M McMahon","year":"2022","unstructured":"McMahon M, O\u2019Dell G, Tan J, S\u00e1rk\u00f6zy A, Vadovics M, Carre\u00f1o JM, et al. Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses. Proc Natl Acad Sci U S A. 2022;119(45):e2206333119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3156_CR53","doi-asserted-by":"publisher","first-page":"2256422","DOI":"10.1080\/22221751.2023.2256422","volume":"12","author":"F Xiong","year":"2023","unstructured":"Xiong F, Zhang C, Shang B, Zheng M, Wang Q, Ding Y, et al. An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza a viruses. Emerg Microbes Infect. 2023;12(2):2256422.","journal-title":"Emerg Microbes Infect"},{"issue":"50","key":"3156_CR54","doi-asserted-by":"publisher","first-page":"eadc9937","DOI":"10.1126\/sciadv.adc9937","volume":"8","author":"K van de Ven","year":"2022","unstructured":"van de Ven K, Lanfermeijer J, van Dijken H, Muramatsu H, Vilas Boas de Melo C, Lenz S, et al. A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets. Sci Adv. 2022;8(50):eadc9937.","journal-title":"Sci Adv"},{"key":"3156_CR55","doi-asserted-by":"crossref","unstructured":"Finn CM, McKinstry KK. Ex Pluribus Unum: the CD4 T cell response against Influenza A Virus. Cells 2024; 13(7).","DOI":"10.3390\/cells13070639"},{"issue":"2","key":"3156_CR56","first-page":"44","volume":"2","author":"G Berke","year":"1985","unstructured":"Berke G. How T lymphocytes kill infected cells. Microbiol Sci. 1985;2(2):44\u20136. 51\u2009\u2013\u200942.","journal-title":"Microbiol Sci"},{"issue":"7","key":"3156_CR57","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/eji.1830230722","volume":"23","author":"D Kyburz","year":"1993","unstructured":"Kyburz D, Speiser DE, Battegay M, Hengartner H, Zinkernagel RM. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Eur J Immunol. 1993;23(7):1540\u20135.","journal-title":"Eur J Immunol"},{"issue":"5","key":"3156_CR58","doi-asserted-by":"publisher","first-page":"e1595","DOI":"10.1002\/wrna.1595","volume":"11","author":"PJ McCown","year":"2020","unstructured":"McCown PJ, Ruszkowska A, Kunkler CN, Breger K, Hulewicz JP, Wang MC, et al. Naturally occurring modified ribonucleosides. Wiley Interdiscip Rev RNA. 2020;11(5):e1595.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"2","key":"3156_CR59","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4049\/jimmunol.1500530","volume":"195","author":"T Eigenbrod","year":"2015","unstructured":"Eigenbrod T, Dalpke AH, Bacterial RNA. An underestimated stimulus for Innate Immune responses. J Immunol. 2015;195(2):411\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"3156_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3 K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23(2):165\u201375.","journal-title":"Immunity"},{"key":"3156_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","volume":"217","author":"O Andries","year":"2015","unstructured":"Andries O, Mc Cafferty S, De Smedt SC, Weiss R, Sanders NN, Kitada T. N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J Control Release. 2015;217:337\u201344.","journal-title":"J Control Release"},{"issue":"1","key":"3156_CR62","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41467-022-28776-w","volume":"13","author":"K Leppek","year":"2022","unstructured":"Leppek K, Byeon GW, Kladwang W, Wayment-Steele HK, Kerr CH, Xu AF, et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat Commun. 2022;13(1):1536.","journal-title":"Nat Commun"},{"issue":"9","key":"3156_CR63","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/mt.2015.103","volume":"23","author":"A Thess","year":"2015","unstructured":"Thess A, Grund S, Mui BL, Hope MJ, Baumhof P, Fotin-Mleczek M, et al. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol Ther. 2015;23(9):1456\u201364.","journal-title":"Mol Ther"},{"key":"3156_CR64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.09.006","volume":"109","author":"KJ Kauffman","year":"2016","unstructured":"Kauffman KJ, Mir FF, Jhunjhunwala S, Kaczmarek JC, Hurtado JE, Yang JH, et al. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo. Biomaterials. 2016;109:78\u201387.","journal-title":"Biomaterials"},{"issue":"7978","key":"3156_CR65","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","volume":"621","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang L, Lin A, Xu C, Li Z, Liu K, et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature. 2023;621(7978):396\u2013403.","journal-title":"Nature"},{"issue":"18","key":"3156_CR66","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1093\/nar\/gkab764","volume":"49","author":"HK Wayment-Steele","year":"2021","unstructured":"Wayment-Steele HK, Kim DS, Choe CA, Nicol JJ, Wellington-Oguri R, Watkins AM, et al. Theoretical basis for stabilizing messenger RNA through secondary structure design. Nucleic Acids Res. 2021;49(18):10604\u201317.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3156_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-2836(05)80019-1","volume":"235","author":"M Kozak","year":"1994","unstructured":"Kozak M. Features in the 5\u2019 non-coding sequences of rabbit alpha and beta-globin mRNAs that affect translational efficiency. J Mol Biol. 1994;235(1):95\u2013110.","journal-title":"J Mol Biol"},{"issue":"21","key":"3156_CR68","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/nar\/gkr695","volume":"39","author":"K Karik\u00f3","year":"2011","unstructured":"Karik\u00f3 K, Muramatsu H, Ludwig J, Weissman D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 2011;39(21):e142.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03156-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03156-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03156-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T08:29:45Z","timestamp":1738139385000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03156-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3156"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03156-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse and chicken experiments with the H5N1 avian influenza viruses challenge were conducted in animal bio-safety level 3 facilities of South China Agricultural University (SCAU) (CNAS BL0011). All animals involved in the experiments were approved by the Institutional Animal Care and Use Committee of SCAU and were treated according to the guideline (2017A002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}